chr5-157731486-A-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000231198.12(THG1L):āc.46A>Gā(p.Ile16Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000329 in 1,610,188 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000231198.12 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
THG1L | NM_017872.5 | c.46A>G | p.Ile16Val | missense_variant | 1/6 | ENST00000231198.12 | NP_060342.2 | |
THG1L | NM_001317824.2 | c.-256A>G | 5_prime_UTR_variant | 1/6 | NP_001304753.1 | |||
THG1L | NM_001317825.2 | c.-326A>G | 5_prime_UTR_variant | 1/6 | NP_001304754.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
THG1L | ENST00000231198.12 | c.46A>G | p.Ile16Val | missense_variant | 1/6 | 1 | NM_017872.5 | ENSP00000231198 | P1 | |
THG1L | ENST00000521655.1 | c.46A>G | p.Ile16Val | missense_variant, NMD_transcript_variant | 1/6 | 2 | ENSP00000428387 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152102Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000807 AC: 20AN: 247734Hom.: 1 AF XY: 0.0000897 AC XY: 12AN XY: 133816
GnomAD4 exome AF: 0.0000343 AC: 50AN: 1457968Hom.: 2 Cov.: 31 AF XY: 0.0000496 AC XY: 36AN XY: 725132
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152220Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74416
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 17, 2022 | The c.46A>G (p.I16V) alteration is located in exon 1 (coding exon 1) of the THG1L gene. This alteration results from a A to G substitution at nucleotide position 46, causing the isoleucine (I) at amino acid position 16 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at